Media briefing on COVID-19 - 12/04/2021
Date:
12/04/2021
00:01:55
CL Hello and good day to wherever you are listening to us today. It is Monday 12th April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian as well as in Portuguese and Hindi.
Now let me introduce th...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Americas/epidemiology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Access to Essential Medicines and Health Technologies, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Health Consortia, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Viral Vaccines/adverse effects, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
WHO SAGE presenting its interim recommendations on the use of AstraZeneca Vaccine against COVID-19
Date:
10/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Betacoronavirus/immunology, Epidemiological Monitoring, Health Communication, Viral Vaccines/supply & distribution, Vaccine Potency, Betacoronavirus/genetics, Mutation/genetics, DNA, Viral/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Risk Groups, COVID-19, AstraZeneca, Oxford
Media briefing on COVID-19 - 15/03/2021
Date:
15/03/2021
00:00:24
CL Hello and good day wherever you are joining us today. It is Monday 15th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference with a special focus on the first anniversary of the COVID-19 Solidarity Response Fund.
Simultaneous translation is provided in the six official languages, Arabic, Chinese, French, English, Spanish...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Viral Vaccines/adverse effects, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Health Systems, Vaccine Potency, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 26/03/2021
Date:
26/03/2021
00:00:18
CL Hello. Good day to... wherever you are listening to us. Today is Friday 26th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi.
The participants today are, p...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Risk Groups, Health Equity, Hospital Bed Capacity, Intensive Care Units, Americas/epidemiology, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 04/12/2020
Date:
04/12/2020
00:00:26
TJ Good evening, everyone, from Geneva, WHO headquarters. My name is Tarik and I'm happy to be back at these press conferences; it's been five months. Welcome to another regular WHO COVID-19 press briefing. We have a number of speakers here in the room but also we will have some guests whom Dr Tedros will introduce in a moment. In the room with us we have WHO Director-General, D...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Social Isolation, Masks, Americas/epidemiology, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Health Personnel/organization & administration, 50207, Access to Essential Medicines and Health Technologies, Investments/economics, Decision Making, Risk Groups, Mutation/genetics, Betacoronavirus/genetics, Vaccine Potency, Clinical Trial, COVID-19, Ghebreyesus, Tedros Adhanom, Pfizer, Reino Unido, BioNTech, BNT162, Covax
